Koninklijke Philips | PHG - Selling And Administration Expenses


Koninklijke Philips reported EUR1.18B in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Abbott USD 4.27B 669M Sep/2026
Baxter International USD 735M 7M Jun/2026
Becton, Dickinson and Co. USD 1.26B 48M Jun/2026
Boston Scientific USD 1.8B 22M Jun/2026
Danaher USD 2.16B 87M Sep/2026
Demant DKK 7.09B 1B Jun/2026
Dexcom USD 358.7M 9M Jun/2026
Edwards Lifesciences USD 561.2M 39M Jun/2026
Fresenius EUR 760M 17M Jun/2026
General Electric Aerospace USD 1.09B 40M Sep/2026
Getinge SEK 2.65B 452M Dec/2024
Globus Medical USD 286.82M 10.95M Jun/2026
GN Store Nord DKK 805M 42M Jun/2026
Hitachi JPY 515.39B 55.69B Jun/2026
Idexx Laboratories USD 288.09M 11.76M Jun/2026
Insulet USD 344.8M 27.6M Jun/2026
Integra LifeSciences USD 161.02M 5.2M Sep/2026
Intuitive Surgical USD 1.08B 465.5M Sep/2026
J&J USD 6.25B 168M Sep/2026
Koninklijke Philips EUR 1.18B 335.05M Mar/2026
Medtronic 3.2B 141M Jun/2026
Philips EUR 1.21B 23M Jun/2026
ResMed USD 290.65M 10.86M Jun/2026
Smith & Nephew USD 1.45B 29M Jun/2026
Steris USD 369.7M 17.9M Jun/2026
Stryker USD 2.12B 32M Jun/2026
Teleflex USD 213.52M 12.5M Jun/2026
Terumo JPY 109.7B 5.11B Jun/2026
Zimmer Biomet Holdings USD 911.6M 61.7M Jun/2026